FindTrial
Sign In

Evaluation of pain and recovery during PACU in patients undergoing thoracoscopic surgery using ultrasound-guided intercostal nerve block therapy

Evaluation of pain and recovery quality during the PACU period in postoperative patients with thoracoscopic lung cancer treated with ultrasound-guided intercostal nerve block

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079183
Enrollment
Unknown
Registered
2023-12-27
Start date
2023-12-27
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

intercostal nerve blockade before surgery (Group pre-ICNB) :Ultrasound guided intercostal nerve blockade before surgery
intercostal nerve blockade after surgery (Group post-ICNB) :Ultrasound guided intercostal nerve blockade after surgery

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: aged 18 to 75 years American Society of Anesthesiologists physical status grade I-II undergoning VATS lobectomy or sleeve lobectomy

Exclusion criteria

Exclusion criteria: individuals with a history of allergy to local anesthetics; chronic analgesics or sedatives use; diagnosed psychologic disorders; presence of coagulopathy; spine or thoracic wall anatomical abnormalities.

Design outcomes

Primary

MeasureTime frame
Postoperative pain;—

Secondary

MeasureTime frame
The total amount of opioid drugs used and the consumption of rescue analgesics within 24 hours after surgery.;Postoperative recovery: Record hypoxemia, drowsiness, postoperative nausea and vomiting (PONV), block-related complications, and sleep quality on the first day after surgery (POD1).;—

Countries

China

Contacts

Public ContactJun Zhang

Department of Anesthesiology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.

snapzhang@aliyun.com+86 181 2129 9259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 6, 2026